Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes.
paper
Cited
Public
- Authors
- Haughey, Heather M; Marshall, Erin; Schacht, Joseph P; Louis, Ashleigh; Hutchison, Kent E
- Year
- 2008
- Journal
- Addiction (Abingdon, England)
- PMID
- 18705688
- DOI
- 10.1111/j.1360-0443.2008.02292.x
- PMCID
- PMC2873690
AIM: To examine whether withdrawal after abstinence and cue-elicited craving were associated with polymorphisms within two genes involved in regulating the endocannabinoid system, cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH). Two single nucleotide polymorphisms (SNPs) in the CNR1 (rs2023239) and FAAH (rs324420) genes, associated previously with substance abuse and functional changes in cannabinoid regulation, were examined in a sample of daily marijuana smokers. PARTICIPANTS: Participants were 105 students at the University of Colorado, Boulder between the ages of 18 and 25 years who reported smoking marijuana daily. MEASUREMENTS: Participants were assessed once at baseline and again after 5 days of abstinence, during which they were exposed to a cue-elicited craving paradigm. Outcome measures were withdrawal and craving collected using self-reported questionnaires. In addition, urine samples were collected at baseline and on day 5 for the purposes of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol (THC-COOH) metabolite analysis. FINDINGS: Between the two sessions, THC-COOH metabolite levels decreased significantly, while measures of withdrawal and craving increased significantly. The CNR1 SNP displayed a significant abstinence x genotype interaction on withdrawal, as well as a main effect on overall levels of craving, while the FAAH SNP displayed a significant abstinence x genotype interaction on craving. CONCLUSIONS: These genetic findings may have both etiological and treatment implications. However, longitudinal studies will be needed to clarify whether these genetic variations influence the trajectory of marijuana use/dependence. The identification of underlying genetic differences in phenotypes such as craving and withdrawal may aid genetically targeted approaches to the treatment of cannabis dependence.
No figures extracted from this document.
1β20 of 35
Next β
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| FAAH and MAGL inhibition: Evolving approaches to treating substance use disorders. | Maddox CJ et al. | β | 2026 | β |
| Urinary Ξ<sup>9</sup>-tetrahydrocannabinol and metabolite concentrations following cannabis use: A systematic review. | McCartney D et al. | β | 2026 | β |
| The CB1 receptor: linking impulsivity and substance use disorder. | Amancio-Belmont O et al. | β | 2025 | β |
| The Endocannabinoid System in the Development and Treatment of Obesity: Searching for New Ideas. | Serefko A et al. | β | 2025 | β |
| Cannabis cravings predict cigarette use in schizophrenia: a secondary analysis from two cannabis abstinence studies. | Johnstone S et al. | β | 2024 | β |
| Exploratory Growth Mixture Modeling of Cannabis-Withdrawal Syndrome Trajectories of Adult Pure Cannabis Dependents During Detoxification: Two Subtypes? | Claus BB et al. | β | 2024 | β |
| An Individuality of Response to Cannabinoids: Challenges in Safety and Efficacy of Cannabis Products. | Kitdumrongthum S et al. | β | 2023 | β |
| Association Between Fatty Acid Amide Hydrolase and Alcohol Response Phenotypes: A Positron Emission Tomography Imaging Study With [<sup>11</sup>C]CURB in Heavy-Drinking Youth. | Best LM et al. | β | 2023 | β |
| Cannabis Pharmacogenomics: A Path to Personalized Medicine. | Babayeva M et al. | β | 2023 | β |
| Fatty acid amide hydrolase C385A polymorphism affects susceptibility to various diseases. | Hosseinzadeh Anvar L et al. | β | 2023 | β |
| <i>FAAH</i> rs324420 Polymorphism: Biological Pathways, Impact on Elite Athletic Performance and Insights for Sport Medicine. | Silva HH et al. | β | 2023 | β |
| Longing to act: Bayesian inference as a framework for craving in behavioral addiction. | Kulkarni KR et al. | β | 2023 | β |
| Transcriptome-wide association study by different approaches reveals candidate causal genes for cannabis use disorder. | Gao J et al. | β | 2023 | β |
| Association of FAAH p.Pro129Thr and COMT p.Ala72Ser with schizophrenia and comorbid substance use through next-generation sequencing: an exploratory analysis. | MartΓnez-MagaΓ±a JJ et al. | β | 2022 | β |
| Biomarkers of the Endocannabinoid System in Substance Use Disorders. | Navarrete F et al. | β | 2022 | β |
| Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders. | Navarro D et al. | β | 2022 | β |
| The genetic aetiology of cannabis use: from twin models to genome-wide association studies and beyond. | Verweij KJH et al. | β | 2022 | β |
| The systems medicine of cannabinoids in pediatrics: the case for more pediatric studies. | O'Dell CP et al. | β | 2022 | β |
| A systems omics-based approach to decode substance use disorders and neuroadaptations. | Veerappa A et al. | β | 2021 | β |
| Endocannabinoid Gene Γ Gene Interaction Association to Alcohol Use Disorder in Two Adolescent Cohorts. | Elkrief L et al. | β | 2021 | β |
| Fatty acid amide hydrolase is lower in young cannabis users. | Jacobson MR et al. | β | 2021 | β |
| Influence of Cannabinoid Receptor 1 Genetic Variants on the Subjective Effects of Smoked Cannabis. | Murphy T et al. | β | 2021 | β |
| Marijuana: A systems-based primer of adverse effects associated with use and an overview of its therapeutic utility. | Kichloo A et al. | β | 2021 | β |
| The CB1R rs2023239 receptor gene variant significantly affects the reinforcing effects of nicotine, but not cue reactivity, in human smokers. | Chukwueke CC et al. | β | 2021 | β |
| The contributions of the endocannabinoid system and stress on the neural processing of reward stimuli. | Filbey FM et al. | β | 2021 | β |
| Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme. | Hindocha C et al. | β | 2020 | β |
| Association of a Variant of <i>CNR1</i> Gene Encoding Cannabinoid Receptor 1 With Gilles de la Tourette Syndrome. | Szejko N et al. | β | 2020 | β |
| Dynamic functional connectivity between nucleus accumbens and the central executive network relates to chronic cannabis use. | Yoo HB et al. | β | 2020 | β |
| FAAH levels and its genetic polymorphism association with susceptibility to methamphetamine dependence. | Zhang W et al. | β | 2020 | β |
| FMRI activation to cannabis odor cues is altered in individuals at risk for a cannabis use disorder. | Kleinhans NM et al. | β | 2020 | β |
| Cannabinoids, Chemical Senses, and Regulation of Feeding Behavior. | Tarragon E et al. | β | 2019 | β |
| <i>CNR1</i> and <i>FAAH</i> variation and affective states induced by marijuana smoking. | Palmer RHC et al. | β | 2019 | β |
| Investigating a novel fMRI cannabis cue reactivity task in youth. | Karoly HC et al. | β | 2019 | β |
| Reward, Control & Decision-Making in Cannabis Use Disorder: Insights from Functional MRI. | Fatima H et al. | β | 2019 | β |
| Testing the role of the posterior cingulate cortex in processing salient stimuli in cannabis users: an rTMS study. | Prashad S et al. | β | 2019 | β |
| Pharmacogenetics of Cannabinoids. | Hryhorowicz S et al. | β | 2018 | β |
| Whole genome sequence study of cannabis dependence in two independent cohorts. | Gizer IR et al. | β | 2018 | β |
| Cannabinoid Receptor 1 Gene by Cannabis Use Interaction on CB1 Receptor Density. | Ketcherside A et al. | β | 2017 | β |
| Cannabis and development of dual diagnoses: A literature review. | Hanna RC et al. | β | 2017 | β |
| Cross-Cultural Effects of Cannabis Use Disorder: Evidence to Support a Cultural Neuroscience Approach. | Prashad S et al. | β | 2017 | β |
| Developmentally Specific Associations Between CNR1 Genotype and Cannabis Use Across Emerging Adulthood. | Ashenhurst JR et al. | β | 2017 | β |
| Mechanisms Underlying Sex Differences in Cannabis Use. | Calakos KC et al. | β | 2017 | β |
| Role of Endocannabinoids on Sweet Taste Perception, Food Preference, and Obesity-related Disorders. | Tarragon E et al. | β | 2017 | β |
| The genetic epidemiology of substance use disorder: A review. | Prom-Wormley EC et al. | β | 2017 | β |
| Craving cannabis: a meta-analysis of self-report and psychophysiological cue-reactivity studies. | Norberg MM et al. | β | 2016 | β |
| Cue-elicited increases in incentive salience for marijuana: Craving, demand, and attentional bias. | Metrik J et al. | β | 2016 | β |
| Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [<sup>11</sup>C]CURB. | Boileau I et al. | β | 2016 | β |
| Genetic and Environmental Factors Associated with Cannabis Involvement. | Bogdan R et al. | β | 2016 | β |
| Genetic variation in FAAH is associated with cannabis use disorders in a young adult sample of Mexican Americans. | Melroy-Greif WE et al. | β | 2016 | β |
| Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium. | Stringer S et al. | β | 2016 | β |
| Longitudinal predictors of cannabis use and dependence in offspring from families at ultra high risk for alcohol dependence and in control families. | Hill SY et al. | β | 2016 | β |
| Magnitude and duration of cue-induced craving for marijuana in volunteers with cannabis use disorder. | Lundahl LH et al. | β | 2016 | β |
| Trajectories of abstinence-induced Internet gaming withdrawal symptoms: A prospective pilot study. | Kaptsis D et al. | β | 2016 | β |
| Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms. | SuΓ‘rez-Pinilla P et al. | β | 2015 | β |
| Common single nucleotide variants underlying drug addiction: more than a decade of research. | BΓΌhler KM et al. | β | 2015 | β |
| Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers. | Lundahl LH et al. | β | 2015 | β |
| Endocannabinoid signalling in reward and addiction. | Parsons LH et al. | β | 2015 | β |
| Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis. | Carey CE et al. | β | 2015 | β |
| Poorer frontolimbic white matter integrity is associated with chronic cannabis use, FAAH genotype, and increased depressive and apathy symptoms in adolescents and young adults. | Shollenbarger SG et al. | β | 2015 | β |
| Validation of the French version of the marijuana craving questionnaire (MCQ) generates a two-factor model. | Chauchard E et al. | β | 2015 | β |
| Have the genetics of cannabis involvement gone to pot? | Agrawal A et al. | β | 2014 | β |
| <i>Considering Cannabis</i>: The Effects of Regular Cannabis Use on Neurocognition in Adolescents and Young Adults. | Lisdahl KM et al. | β | 2014 | β |
| Pharmacogenetics of the G protein-coupled receptors. | Thompson MD et al. | β | 2014 | β |
| The Genetics, Neurogenetics and Pharmacogenetics of Addiction. | Demers CH et al. | β | 2014 | β |
| The prevalence of cannabis withdrawal and its influence on adolescents' treatment response and outcomes: a 12-month prospective investigation. | Greene MC et al. | β | 2014 | β |
| Association of a functional FAAH polymorphism with methamphetamine-induced symptoms and dependence in a Malaysian population. | Sim MS et al. | β | 2013 | β |
| Cannabis cue-induced brain activation correlates with drug craving in limbic and visual salience regions: preliminary results. | Charboneau EJ et al. | β | 2013 | β |
| Considering gender in cannabinoid research: a step towards personalized treatment of marijuana addicts. | Fattore L | β | 2013 | β |
| Evidence for the involvement of cannabinoid receptors' polymorphisms in the pathophysiology of human diseases. | Vasileiou I et al. | β | 2013 | β |
| Impulsivity, variation in the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes, and marijuana-related problems. | Bidwell LC et al. | β | 2013 | β |
| Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction. | Panlilio LV et al. | β | 2013 | β |
| Integrating brain and behavior: evaluating adolescents' response to a cannabis intervention. | Feldstein Ewing SW et al. | β | 2013 | β |
| Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addiction. | OliΓ¨re S et al. | β | 2013 | β |
| Neural responses associated with cue-reactivity in frequent cannabis users. | Cousijn J et al. | β | 2013 | β |
| Allele-specific differences in activity of a novel cannabinoid receptor 1 (CNR1) gene intronic enhancer in hypothalamus, dorsal root ganglia, and hippocampus. | Nicoll G et al. | β | 2012 | β |
| A preliminary examination of how serotonergic polymorphisms influence brain response following an adolescent cannabis intervention. | Feldstein Ewing SW et al. | β | 2012 | β |
| Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users. | Schacht JP et al. | β | 2012 | β |
| Cannabis cue-elicited craving and the reward neurocircuitry. | Filbey FM et al. | β | 2012 | β |
| Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence. | Hillard CJ et al. | β | 2012 | β |
| Enhancement of the behavioral effects of endogenous and exogenous cannabinoid agonists by phenylmethyl sulfonyl fluoride. | Vann RE et al. | β | 2012 | β |
| The endocannabinoid system and emotional processing: pathophysiology and therapeutic potential. | Finn DP et al. | β | 2012 | β |
| The genetic basis of the endocannabinoid system and drug addiction in humans. | LΓ³pez-Moreno JA et al. | β | 2012 | β |
| Acute Effects of Marijuana Smoking on Negative and Positive Affect. | Metrik J et al. | β | 2011 | β |
| Cue-induced craving for marijuana in cannabis-dependent adults. | Lundahl LH et al. | β | 2011 | β |
| Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors. | Serrano A et al. | β | 2011 | β |
| Linkage analyses of stimulant dependence, craving, and heavy use in American Indians. | Ehlers CL et al. | β | 2011 | β |
| Reactivity to in vivo marijuana cues among cannabis-dependent adolescents. | Gray KM et al. | β | 2011 | β |
| Stress- and cue-elicited craving and reactivity in marijuana-dependent individuals. | McRae-Clark AL et al. | β | 2011 | β |
| Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues. | Filbey FM et al. | β | 2010 | β |
| Linkage analyses of cannabis dependence, craving, and withdrawal in the San Francisco family study. | Ehlers CL et al. | β | 2010 | β |
| More aroused, less fatigued: fatty acid amide hydrolase gene polymorphisms influence acute response to amphetamine. | Dlugos AM et al. | β | 2010 | β |
| New horizons for therapeutics in drug and alcohol abuse. | Jupp B et al. | β | 2010 | β |
| Candidate genes for cannabis use disorders: findings, challenges and directions. | Agrawal A et al. | β | 2009 | β |
| Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications. | Onaivi ES | β | 2009 | β |
| Intermediate cannabis dependence phenotypes and the FAAH C385A variant: an exploratory analysis. | Schacht JP et al. | β | 2009 | β |
| Marijuana craving in the brain. | Filbey FM et al. | β | 2009 | β |